Scientists have identified and modelled a distinct biology for paediatric AML
Scientists have identified and modelled a distinct biology for paediatric acute myeloid leukaemia, one of the major causes of death in children.
Dec 11, 2018
0
29
Scientists have identified and modelled a distinct biology for paediatric acute myeloid leukaemia, one of the major causes of death in children.
Dec 11, 2018
0
29
Around 22,000 people will be diagnosed this year in the US with acute myeloid leukemia (AML), the second most common type of leukemia diagnosed in adults and children, and the most aggressive of the leukemias. Less than one ...
Aug 1, 2019
0
47
The number of cases of idiopathic pulmonary fibrosis (IPF) has continued to rise significantly in the first decade of the 21st century and could lead to more deaths than ovarian cancer, lymphoma, leukaemia, or kidney cancer, ...
Apr 28, 2011
0
0
Glasgow scientists have uncovered important information about how cancer cells become resistant to certain treatments, according to research published in Nature Communications.
Nov 17, 2021
0
82
Chemotherapy is one of the most important treatments for all types of cancer. It involves the use of drugs that kill abnormally multiplying cells. The therapy uses one or more drugs in combination and has been practised since ...
Jun 27, 2014
0
0
Researchers at the University of Southampton have shed new light on why and how a new class of drug is effective at fighting off leukaemia.
Nov 29, 2016
0
31
Researchers at The University of Manchester have discovered that a protein (5T4) found on the surface of cells contributes to chemotherapy resistance in the most common type of childhood leukaemia. Using a novel approach, ...
May 18, 2017
0
30
Scientists have described new results of a blood cancer study as 'outstanding' in tackling previously untreatable forms of chronic lymphocytic leukaemia (CLL).
Apr 27, 2017
0
6
Patients living with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for use on the NHS in England.
Mar 8, 2019
0
1
Early testing of a new drug combination that attacks the most common form of leukaemia on multiple fronts has shown great promise in targeting cancer cells.
Oct 17, 2016
0
1